ÂÜÀòÂÒÂ×

Hakan Bagci, PhD is an accomplished professional with experience in various scientific and business roles. Currently serving as an Executive at Imperial College London, Hakan has made significant contributions in the fields of immunology and neurodegenerative disorders. As the Interim CEO at AniML, Hakan has successfully led the commercialization of sensor technologies. Hakan is also actively involved in entrepreneurship and enterprise initiatives, having founded the Imperial Postdocs & Fellows Enterprise Network. With a strong educational background in molecular biology and biochemistry, Hakan continues to make a profound impact in the scientific and business communities.